“Buy and bill” is a term used by health care providers when an office or facility purchases LUCENTIS, then bills an insurer for reimbursement. Once the bill is submitted, your office is reimbursed for the product. With buy and bill, you maintain a stock of LUCENTIS, giving you the flexibility to treat your patients when clinically appropriate. If you qualify to continue using the CMS 1500 claim form, follow these steps:
Genentech has contracted with a network of authorized specialty distributors and wholesalers to service customers that choose to purchase LUCENTIS® (ranibizumab injection) through the buy and bill model. Customers can purchase LUCENTIS through authorized specialty distributors and wholesalers that have made a commitment to product integrity. These partners have agreed to distribute only products purchased directly from Genentech and not distribute LUCENTIS through secondary channels.
Please contact us for a list of authorized distributors.
If the LUCENTIS prescribed for a labeled indication was spoiled and unable to be administered, the product might be eligible for replacement through the Genentech Spoilage Replacement Program.*
LUCENTIS has been reconstituted and is unusable due to one of the following events:
For all quality- or stability-related issues, please contact Genentech Medical Communications at (800) 821-8590.
For expired product returns, please contact Genentech Customer Operations at (800) 551-2231.
To request replacement product:
Please be sure to retain all intact vials. Unless the vial(s) is broken, all products must be returned. If the vial(s) is broken, a completed Certification of Destruction form is required.
|*||Subject to certain limitations and conditions. The Spoilage Replacement Program covers infused or injected Genentech products. Genentech has the right to modify or discontinue the Spoilage Replacement Program at any time without notice.|